KOD Stock Analysis: Buy, Sell, or Hold?
KOD - Kodiak Sciences Inc Common Stock
$43.26
2.16 (5.26%)
▲
5d:
+12.95%
30d:
+27.35%
90d:
+3.12%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 12, 2026
27d
Get Alerted When KOD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called KOD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: KOD is 12.0% above its trading range ($38.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: KOD is 12.0% above its trading range ($38.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: KOD is currently trading at $43.26, which is considered extended relative to its 30-day fair value range of $32.68 to $38.62.
Technical Outlook: Technically, KOD is in a uptrend. The price is approaching resistance at $44.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: KOD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $62.67 (+44.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KOD is in a uptrend. The price is approaching resistance at $44.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: KOD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $62.67 (+44.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$32.68 -
$38.62
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding KOD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.0% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 44.9% below Wall St target ($62.67)
Trading Range Analysis
30-Day Trading Range
$32.68 -
$38.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$35.77
Resistance Level
$44.29
Current Trend
Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.88
Wall Street Target
$62.67
(+44.9%)
Share & Embed Analysis
Last updated: July 14, 2026 8:52 PM ET
Data refreshes hourly during market hours. Next update: 9:52 PM
Data refreshes hourly during market hours. Next update: 9:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KOD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 58 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 46 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 60 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$46 | 65 BUY |
Advanced KOD Option Strategies
Professional options setups generated by AI based on today's KOD price and gamma walls.
